BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32274740)

  • 21. Heparanase: one molecule with multiple functions in cancer progression.
    Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
    Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans.
    Gingis-Velitski S; Zetser A; Kaplan V; Ben-Zaken O; Cohen E; Levy-Adam F; Bashenko Y; Flugelman MY; Vlodavsky I; Ilan N
    J Biol Chem; 2004 Oct; 279(42):44084-92. PubMed ID: 15292202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
    Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
    Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research advancement on heparanase in tumor metastasis].
    Li ZH; Yang SM
    Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of heparanase from a rat parathyroid cell line.
    Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
    J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
    Chhabra M; Ferro V
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
    Ramani VC; Purushothaman A; Stewart MD; Thompson CA; Vlodavsky I; Au JL; Sanderson RD
    FEBS J; 2013 May; 280(10):2294-306. PubMed ID: 23374281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
    Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I
    FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
    Lanzi C; Zaffaroni N; Cassinelli G
    Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction.
    Iriyama S; Ono T; Aoki H; Amano S
    J Dermatol Sci; 2011 Dec; 64(3):223-8. PubMed ID: 22005029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-faceted substrate specificity of heparanase.
    Peterson SB; Liu J
    Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI-88 and Related Heparan Sulfate Mimetics.
    Chhabra M; Ferro V
    Adv Exp Med Biol; 2020; 1221():473-491. PubMed ID: 32274723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Anticoagulant Heparins as Heparanase Inhibitors.
    Cassinelli G; Torri G; Naggi A
    Adv Exp Med Biol; 2020; 1221():493-522. PubMed ID: 32274724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparanase - Discovery and Targets.
    Lindahl U; Li JP
    Adv Exp Med Biol; 2020; 1221():61-69. PubMed ID: 32274706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Versatile role of heparanase in inflammation.
    Goldberg R; Meirovitz A; Hirshoren N; Bulvik R; Binder A; Rubinstein AM; Elkin M
    Matrix Biol; 2013 Jun; 32(5):234-240. PubMed ID: 23499528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.
    Nguyen TK; Paone S; Chan E; Poon IKH; Baxter AA; Thomas SR; Hulett MD
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
    Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
    BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential of heparanase as a therapeutic target in cancer.
    Pisano C; Vlodavsky I; Ilan N; Zunino F
    Biochem Pharmacol; 2014 May; 89(1):12-9. PubMed ID: 24565907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of heparanase in migration of microglial cells.
    Takahashi H; Matsumoto H; Smirkin A; Itai T; Nishimura Y; Tanaka J
    Biochim Biophys Acta; 2008 Apr; 1780(4):709-15. PubMed ID: 18222122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparan sulfate and heparanase as modulators of breast cancer progression.
    Gomes AM; Stelling MP; Pavão MS
    Biomed Res Int; 2013; 2013():852093. PubMed ID: 23984412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.